MediSapiens Supports Bayer’s Future Clinical Trial Program (Updated)

MediSapiens supports Bayer in its Future Clinical Trials program, where Bayer is working to transform clinical trials with data science and patient-centricity. MediSapiens provides its data model knowledge (such as OMOP), data quality capabilities and data management know-how to Bayer, among others. To hear more, listen to Bayer’s Jussi Leinonen present the Future Clinical Trials…